Hand Foot and Mouth Disease
📧 Sign up to get email alerts when something new happens for Hand Foot and Mouth Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell). [Phase 1, Phase 2]
This clinical trial update reports on tolerability, safety, and immunogenicity of a tetravalent inactivated enterovirus vaccine (Vero cell) …
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for an inactivated bivalent enterovirus vaccine (Vero cell) from Sinovac to prevent hand, foot and mouth d…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Phase I Clinical Trial of Enterovirus Type71 - Coxsackievirus Type A16 Bivalent Vaccine [Phase 1]
Phase I study of a bivalent Enterovirus 71 and Coxsackievirus A16 vaccine for Hand, Foot and Mouth Disease, not yet recruiting.
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Study on the Persistence of Immunity Following EV71 Vaccination
A clinical trial update showing enrollment by invitation for a study assessing the persistence of immunity after vaccination against enterov…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Clinical Trial of Pegylated Interferon α-2b Via Nebulization for Treatment of Hand, Foot, and Mouth Disease . [NA]
A clinical trial is evaluating pegylated interferon α-2b delivered by nebulization for hand, foot, and mouth disease and enrollment is curre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-01Clinical Trial Update: Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell) [Phase 3]
A Phase 3 clinical trial update evaluating the efficacy, safety, and immunogenicity of a bivalent inactivated enterovirus vaccine (Vero cell…
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: Artificial Intelligence-driven Virtual Standardized Pediatric Patients Trial [NA]
An AI-driven virtual standardized pediatric patient platform is in ongoing recruitment for studies across multiple pediatric conditions, inc…
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: Propolis as a Treatment Option for Hand Foot and Mouth Disease [Phase 2, Phase 3]
This clinical trial update reports the completion of Phase 2 and Phase 3 trials evaluating propolis as a treatment option for hand, foot, an…
-
CLINICAL_TRIALS research · 2024-04-09Clinical Trial Update: Hand, Foot, and Mouth Disease: Could EPs®7630 be a Treatment Option [Phase 2, Phase 3]
Clinical trial update for EPs®7630 in Hand, Foot, and Mouth Disease undergoing Phase 2 and Phase 3 evaluation; status completed.
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine [Phase 4]
A Phase 4 clinical trial assesses the immunogenicity of an inactivated EV71 vaccine combined with hepatitis B and group A meningococcal vacc…
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 Vaccine [Phase 4]
A phase 4 trial updating on lot-to-lot consistency for three commercial batches of an Enterovirus 71 vaccine.
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: A Protected Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants and Children [Phase 3]
Phase 3 trial update evaluating the efficacy of an inactivated EV71 vaccine (KMB-17) for preventing hand, foot, and mouth disease in Chinese…
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: A Phase II, Safety and Efficacy Study of Inactivated EV 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants [Phase 2]
Phase II trial assessing safety and efficacy of an inactivated EV71 vaccine (Human Diploid Cell, KMB-17) in Chinese infants/children for han…
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: The Phase IVb of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Children [Phase 4]
Phase IVb trial update for an inactivated Enterovirus 71 vaccine (KMB-17) in Chinese children for Hand, Foot and Mouth Disease (HFMD) has co…
-
CLINICAL_TRIALS trial_result · 2023-07-05Clinical Trial Update: Immunogenicity and Safety of Enterovirus Type 71 Vaccine,Inactivated(Vero Cells) in Volunteers Aged From 6 to 71 Months [Phase 2]
Phase 2 trial results reporting immunogenicity and safety of an inactivated Enterovirus Type 71 vaccine (Vero cell–based) in volunteers aged…
-
CLINICAL_TRIALS trial_result · 2022-07-13Clinical Trial Update: The Immunogenicity and Safety of the Vaccination of Inactivated Enterovirus 71 Vaccine and Seasonal Influenza Vaccine [Phase 4]
Phase 4 clinical trial evaluating the immunogenicity and safety of an inactivated Enterovirus 71 vaccine combined with seasonal influenza va…
-
CLINICAL_TRIALS trial_result · 2022-06-10Clinical Trial Update: An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell) [Phase 4]
Phase 4 clinical trial update evaluating the durability of immunity for an inactivated Enterovirus 71 vaccine (Vero cell) in Hand, Foot and …
-
CLINICAL_TRIALS trial_result · 2022-05-26Clinical Trial Update: Clinical Trial of Enterovirus 71（EV71） Inactivated Vaccine in Children Aged 36-71 Months [Phase 3]
Phase 3 trial update for an inactivated EV71 vaccine in children 36-71 months completed.
-
CLINICAL_TRIALS trial_result · 2021-10-29Clinical Trial Update: Sucralfate to Improve Oral Intake in Children With Infectious Oral Ulcers: a Randomized, Double-blind, Placebo-Controlled Trial [Phase 2]
Phase 2 randomized trial evaluating sucralfate to improve oral intake in children with infectious oral ulcers; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization Vaccines [Phase 4]
Phase 4 trial evaluating safety and immunogenicity of administering EV71 vaccine concomitantly with Expanded Programme on Immunization vacci…
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: Immunogenicity and Safety of Two Different Commercial EV71 Vaccines [Phase 4]
Phase 4 trial update evaluating immunogenicity and safety of two commercial EV71 vaccines for Hand, Foot and Mouth Disease has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI Vaccines [Phase 4]
Phase 4 trial assessing safety and immunogenicity of giving EV71 vaccine alongside EPI vaccines.
-
CLINICAL_TRIALS trial_result · 2021-07-27Clinical Trial Update: Efficacy Trial of a Commercial EV71 Vaccine [Phase 4]
Phase 4 efficacy trial of a commercial EV71 vaccine for Hand, Foot and Mouth Disease has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-24Clinical Trial Update: Efficacy Evaluation for Inactivated Vaccine (Vero Cell) Against EV71 [Phase 4]
Phase 4 efficacy evaluation of an inactivated Vero cell EV71 vaccine has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-24Clinical Trial Update: Immunity and Safety of Inactivated Enterovirus 71 Vaccine Post-marketing Among Children Aged 6-35 Months in China [Phase 4]
Phase 4 post-marketing trial evaluating the immunogenicity and safety of an inactivated Enterovirus 71 vaccine in children aged 6-35 months …